Virtus LifeSci Biotech Clinical Trials ETF (NYSEARCA:BBC – Get Free Report)’s share price was down 0.7% on Thursday . The company traded as low as $30.11 and last traded at $30.21. Approximately 2,226 shares traded hands during mid-day trading, a decline of 28% from the average daily volume of 3,112 shares. The stock had previously closed at $30.44.
Virtus LifeSci Biotech Clinical Trials ETF Trading Down 0.7 %
The stock has a fifty day simple moving average of $27.84 and a 200-day simple moving average of $27.22.
Virtus LifeSci Biotech Clinical Trials ETF Company Profile
The Virtus LifeSci Biotech Clinical Trials ETF (BBC) is an exchange-traded fund that mostly invests in health care equity. The fund tracks an equally weighted index of US-listed biotech companies with lead drugs in various phases of clinical trials. BBC was launched on Dec 16, 2014 and is managed by Virtus.
Recommended Stories
- Five stocks we like better than Virtus LifeSci Biotech Clinical Trials ETF
- What is the Nasdaq? Complete Overview with History
- Taiwan Semiconductor Soars on Earnings With More Room to Run
- Why Are Stock Sectors Important to Successful Investing?
- Is Lucid Group Nearing the Bottom? What Investors Should Know
- Airline Stocks – Top Airline Stocks to Buy Now
- 90% Gain Possible? Analysts Are Bullish on Joby Aviation
Receive News & Ratings for Virtus LifeSci Biotech Clinical Trials ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Virtus LifeSci Biotech Clinical Trials ETF and related companies with MarketBeat.com's FREE daily email newsletter.
